← Back to all trials
Recruiting
NCT05617391
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
Conditions: Childhood Cancer, Cardiomyopathy, Primary
Sex: All
Ages: 22 Years – N/A
Enrollment: 1300
Sponsor: St. Jude Children's Research Hospital
Location: United States
Summary
The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer.Primary ObjectiveTo evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk.Secondary ObjectiveTo build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.
Eligibility Criteria
Inclusion Criteria:SJLIFE participant and 22 years of age or older at time of enrollmentParticipant or legal guardian is able and willing to give informed consentAt least 5 years after childhood cancer diagnosisExclusion Criteria:Been diagnosed with cardiomyopathy on previous SJLIFE ECGCurrently on heart medication
Source: ClinicalTrials.gov (NCT05617391). StuddyBuddy aggregates publicly available trial information.
